(CRMZ)

Preview

This is a Preview, click here for the full commercial credit report.

Generex Biotechnology Corporation 33 Harbour Square Suite 202 Phone: (416) 364-2551 Toronto, ON  M5J 2G2  Canada Ticker: GNBT

Business Summary Generex Biotechnology Corporation (Generex) is a development-stage company. The Company is engaged in the research, development and commercialization of drug delivery systems and technologies. The Company is focused on its technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator. Through its wholly owned subsidiary, Antigen Express, Inc. (Antigen), the Company has expanded its focus to include immunomedicines incorporating vaccine formulations. The Company’s subsidiaries include Generex Pharmaceuticals Inc., Generex (Bermuda), Inc., Generex Pharmaceuticals (USA) LLC and Generex Marketing & Distribution Inc. In April 1999, the Company completed a reorganization in which it merged with Generex Idaho. In September 2009, the Company announced the incorporation of SIA Generex Biotechnology BALTIC as a wholly owned subsidiary.

Financial Information Financial Ratings: Z'' Score  FRISK Score Latest Financial Statements and Analyses: 4/30/2010    Annual Financials    Quarterly Financials     Current Fiscal Period: 3Q 2010 Fiscal Year End: December Last Audit: 7/31/2009 Auditors: MSCM LLP Audit Opinion: Unqualified with Explanation SEC Filings: Management Discussion & Analysis    Full Filings

News Stories Date Headline 8/27/2010 Generex Informs Stockholders of Minimum Exchange Ratio for Reverse Stock Split Proposal to be Considered at the Special Meeting of Stockholders on September 17, 2010 84 additional News Stories available in full report.

Industries Type Code Description Sector HEALTH Healthcare Industry BIOTRX Biotechnology & Drugs SIC 2834 Pharmaceutical Preparations 8731 Commercial Physical And Biological Research 6719 Offices Of Holding Companies, Not Elsewhere Classified NAICS 54171 Research and Development in the Physical, Engineering, and Life Sciences 325412 Pharmaceutical Preparation Manufacturing 551112 Offices of Other Holding Companies

Management Title Name Age Title Date Start Date Chairperson of the Board, President, Chief Executive Officer Anna E. Gluskin 58 11/7/2002 9/1/1997 Chief Financial Officer, Chief Operating Officer, Treasurer, Secretary, Director Rose C. Perri 42 4/1/2005 9/1/1997 Independent Director John P. Barratt 65 3/19/2003 3/19/2003 Independent Director Brian T. McGee 49 3/16/2004 3/16/2004 Independent Director Nola E. Masterson 62 5/1/2007 5/1/2007

Business Names Business Name Antigen Express, Inc. Generex (Bermuda), Inc. Generex Biotechnology BALTIC Generex Marketing & Distribution Inc. Generex Pharmaceuticals, Inc.

General Information Number of Employees: 43 (As of 9/30/2009) Outstanding Shares: 266,055,346 (As of 6/10/2010) Shareholders: 678 (As of 7/31/2009) Stock Exchange: NASD Federal Tax Id: 980178636 Fax Number: (416) 364-9363 Email Address: info@generex.com

Home | Directory | About Us | Products | Service Options | Pricing | Register | Contact Us | Testimonials | Hours of Availability | Careers | Events | Resources | Investors | Sign In
 
Copyright © by CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.
By using this website, you accept the Terms of Use Agreement.
Contact Us: 845.230.3000